Norton, Elizabeth B.
Tulane University
4 papers on CoChatORCID 0000-0002-8426-3515
Most cited papers
- Verified
Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant
Norton, E. B., Lawson, L. B., Freytag, L. C., & Clements, J. D. (2011) · Clinical and Vaccine Immunology
Escherichia coli research studiesImmunotherapy and Immune Responses
Cited by 221
- Verified
The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model
Norton, E. B., Bauer, D. L., Weldon, W. C., Oberste, M. S., Lawson, L. B., & Clements, J. D. (2015) · Vaccine
Immunotherapy and Immune ResponsesViral Infections and Immunology Research
Cited by 76
- Verified
Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system
White, J. A., Blum, J. S., Hosken, N. A., Marshak, J. O., Duncan, L., Zhu, C., Norton, E. B., Clements, J. D., Koelle, D. M., Chen, D., et al. (2014) · Human Vaccines & Immunotherapeutics
Advanced Drug Delivery SystemsImmunotherapy and Immune Responses
Cited by 51
- Verified
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial
Crothers, J. W., Ross Colgate, E., Cowan, K. J., Dickson, D. M., Walsh, M., Carmolli, M., Wright, P. F., Norton, E. B., & Kirkpatrick, B. D. (2022) · Vaccine
Viral Infections and Immunology ResearchImmunotherapy and Immune Responses
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free